BCL2-Interacting Killer (Apoptosis-Inducing) (BIK) (pSer33) Peptid
BIK
Reaktivität: Human
Wirt: Synthetic
BP
-
- Target Alle BIK Produkte
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
- Protein Region
- pSer33
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
- The peptide is used to block Anti-BIK (pT33) Antibody reactivity.
-
-
- Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
- Haltbarkeit
- 12 months
-
- Target
- BIK (BCL2-Interacting Killer (Apoptosis-Inducing) (BIK))
- Synonyme
- BIK Peptide, Biklk Peptide, Blk Peptide, Nbk Peptide, BIP1 Peptide, BP4 Peptide, NBK Peptide, si:dkey-31f5.6 Peptide, BCL2 interacting killer Peptide, BCL2-interacting killer Peptide, BCL2-interacting killer (apoptosis-inducing) Peptide, BIK Peptide, Bik Peptide, bik Peptide
- Hintergrund
- NBK, Bcl-2-interacting killer, Apoptosis inducer NBK, BIP1, BP4
- Gen-ID
- 638
- UniProt
- Q13323
-
Sie sind hier:
